Japan, June 10 -- AMGEN INC has got intellectual property rights for 'RNAi CONSTRUCTS FOR INHIBITING ASGR1 EXPRESSION AND METHODS OF USE THEREOF.' Other related details are as follows:
Application Number: JP,2024-000208
Category (FI): C12N15/113,140@Z,C12N15/87@Z,A61K39/395@D,C07K16/28,C12P21/08,A61K39/395@N,A61K31/7125,A61K31/712,A61K47/68,A61K31/713,A61P9/00
Stage: Grant (IP right granted following substantive examination.)
Filing Date: Jan. 4, 2024
Publication Date: Feb. 9, 2024
The original document can be viewed at: https://www.j-platpat.inpit.go.jp/p0100
Disclaimer: Curated by HT Syndication.
